Home / Auditor changes / Pelthos Therapeutics Inc.
Filed 2026-05-21 路 Form 8-K 路 Accession 0001919246-26-000078 micro
Price before filing: $27.11 (2026-05-20 close, split/dividend-adjusted)
Market cap at flag: $89.7M (2026-05-21) 路 Latest: $71.3M (2026-10-16)
| Window | PTHS | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +8.0% | +0.7% | +7.3% | 2026-06-22 |
| 90 days | -4.8% | +4.0% | -8.8% | 2026-08-19 |
| 180 days | pending | pending | until 2026-11-17 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 4 insiders sold $57K (8 sales)
30 days after: 2 insiders sold $48K (3 sales); 1 insider bought $1000K (2 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Friedberg Ezra M Director | Sale | 293 | $20.51 | $6K | yes | Form 4 |
| 2026-04-02 | Friedberg Ezra M Director | Sale | 265 | $21.36 | $6K | yes | Form 4 |
| 2026-04-02 | Greenleaf Peter Director | Sale | 420 | $20.52 | $9K | yes | Form 4 |
| 2026-04-02 | Greenleaf Peter Director | Sale | 377 | $21.36 | $8K | yes | Form 4 |
| 2026-04-02 | Malamut Richard Director | Sale | 310 | $20.51 | $6K | yes | Form 4 |
| 2026-04-02 | Malamut Richard Director | Sale | 280 | $21.36 | $6K | yes | Form 4 |
| 2026-04-02 | Pauls Matthew Director | Sale | 415 | $20.52 | $9K | yes | Form 4 |
| 2026-04-02 | Pauls Matthew Director | Sale | 371 | $21.36 | $8K | yes | Form 4 |
| 2026-05-21: red flag filed | |||||||
| 2026-05-22 | Francis Knuettel II CFO, Treas & Secty | Sale | 1,500 | $26.84 | $40K | no | Form 4 |
| 2026-06-11 | Davis Todd C Director | Purchase | 35,445 | $27.80 | $986K | no | Form 4 |
| 2026-06-11 | Davis Todd C Director | Purchase | 503 | $28.73 | $14K | no | Form 4 |
| 2026-06-15 | Friedberg Ezra M Director | Sale | 224 | $27.12 | $6K | yes | Form 4 |
| 2026-06-15 | Friedberg Ezra M Director | Sale | 59 | $27.94 | $2K | yes | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-02-20 to 2026-06-20. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"(the "Company") approved the dismissal of CBIZ CPAs P.C. ("CBIZ"), as the Company's independent registered public accounting firm."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: dismissed
Disagreements reported: no
Former auditor: CBIZ CPAs P.C. · New auditor: Grant Thornton LLP
Why this score: also within 90 days: Going-concern doubt, Non-reliance / restatement
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.